Neutropenic Enterocolitis: Clinical Features and Outcomes
Hamzah Abu‐Sbeih(The University of Texas MD Anderson Cancer Center), Yinghong Wang(Hangzhou Center for Disease Control and Prevention), Faisal S. Ali(Beth Israel Deaconess Medical Center), Ray Hachem(The University of Texas MD Anderson Cancer Center), Robert R. Jenq(City Of Hope National Medical Center), Niharika Mallepally(University of California, Los Angeles), Javier A. Adachi(The University of Texas MD Anderson Cancer Center), Ellie Chen(Baylor College of Medicine), Mehmet Altan(The University of Texas MD Anderson Cancer Center), Yang Lü(Nanfang Hospital), Pablo C. Okhuysen(The University of Texas MD Anderson Cancer Center), Wei Qiao(The University of Texas MD Anderson Cancer Center), Wenyi Luo(The University of Texas MD Anderson Cancer Center), Wai Chin Foo(The University of Texas MD Anderson Cancer Center)
Cited by 20
Related Papers
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation
|Blood|2014|880
A Comparison of Two Antimicrobial-Impregnated Central Venous Catheters
|New England Journal of Medicine|1999|806
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease
|Biology of Blood and Marrow Transplantation|2015|762